View in EDS HTML Full Text PDF Full Text

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma.
Authors: Lin, Jun-Peng1,2,3 (AUTHOR), Zhuang, Feng-Nian1,2,3 (AUTHOR), Chen, Wei-Jie1,2,3 (AUTHOR), Lin, Zhou1,4 (AUTHOR), Chen, Yu-Jie1,2,3 (AUTHOR), Chen, Xiao-Feng1,2,3 (AUTHOR), Lin, Hui1,2,3 (AUTHOR), He, Hao1,2,3 (AUTHOR), Wang, Peiyuan1,2,3 (AUTHOR), Zhou, Hang1,2,3 (AUTHOR), Wei, Wen-Wei1,2,3 (AUTHOR), Gao, Peng-Qiang1,2,3 (AUTHOR), Liu, Shuo-Yan1,2,3 (AUTHOR) shuoyanliu2010@163.com, Wang, Feng1,2,3 (AUTHOR) wfmd120@163.com
Source: Journal of Translational Medicine. 8/16/2025, Vol. 23 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-025-06672-3